Aurobindo Pharma calls off its acquisition of Cronus Pharma
The acquisition was expected to be completed in eight weeks, and it would have provided it with a foothold in the US $ 48 billion global animal health market
The acquisition was expected to be completed in eight weeks, and it would have provided it with a foothold in the US $ 48 billion global animal health market
Purchase price of US $ 1.5 billion upfront and up to USD 500 million in success-based milestone payments
In the interim, the statutory approvals obtained by the company under SEBI ICDR have lapsed in accordance with applicable law and are required to be re-obtained
Novasep's viral vector business is an excellent strategic fit as Thermo Fisher continues to expand its capabilities for cell and gene vaccines and therapies globally," said Michel Lagarde, executive vice president, Thermo Fisher.
At the center of the collapse is opposition from the Federal Trade Commission
The initial consideration for the transaction is US$ 12 million
Rivotril is the innovator/ reference brand of clonazepam and is widely prescribed for the management of neurological and psychiatric conditions
The expanded ownership is expected to improve access to Cialis for millions of men in Asia affected by ED and BPH
The endorsement follows overwhelming support for the share swap preceding the merger,
Remidex manufactures micronutrient premixes and nutraceuticals,
Subscribe To Our Newsletter & Stay Updated